OrthoRADIO Podcast : Arthroplasty Dialogues : Episode 1 : Discussion on recent JBJS Publication: Intravenous Versus Topical Tranexamic Acid in Total Knee Arthroplasty
The OrthoRADIO Podcast “Arthroplasty Dialogues” interviews Brian P. Chalmers, MD, hip and knee surgeon at HSS, about the results of a study he co-authored and published in The Journal of Bone & Joint Surgery (JBJS).
The study compared intravenous (IV) administration of tranexamic acid (TXA) to topical administration after total knee arthroplasty in 640 patients, the largest comparison study done finding both methods effective.
Dr. Chalmers discussed the clinical significance of this study and said, “There are a number of reasons why it has become ubiquitous to use tranexamic acid in the U.S. The first is that data, including this study, show that it does significantly reduce blood loss during and after surgery, which has led to very low rates of transfusion for primary and revision hip and knee arthroplasty.”
This podcast was previously available on Orthotvonline.com.